Literature DB >> 6180073

Thymosin treatment modulates production of interferon.

K Y Huang, P D Kind, E M Jagoda, A L Goldstein.   

Abstract

Mesh：

Substances：

Year:  1981        PMID： 6180073     DOI： 10.1089/jir.1981.1.411

Source DB:  PubMed          Journal:  J Interferon Res        ISSN： 0197-8357


× No keyword cloud information.
  9 in total

1.  Modulation of interleukin 2 receptor expression on normal human lymphocytes by thymic hormones.

Authors:  M B Sztein; S A Serrate; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

2.  Modulation of NK activity by thymic hormones: in vitro effects of thymostimulin.

Authors:  A M Liberati; S Cinieri; M Fizzotti; M Schippa; S Ascani; V De Angelis; M Senatore; L Palmisano
Journal:  Med Oncol Tumor Pharmacother       Date:  1989

3.  Primary structure of rat thymus prothymosin alpha.

Authors:  A A Haritos; R Blacher; S Stein; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

Review 4.  Thymosins and anti-thymosins: properties and clinical applications.

Authors:  A L Goldstein; R S Schulof; P H Naylor; N R Hall
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

5.  Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.

Authors:  M M Zatz; J Oliver; C Samuels; A B Skotnicki; M B Sztein; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

Review 6.  Roles of thymosins in cancers and other organ systems.

Authors:  Changyi Chen; Min Li; Hui Yang; Hong Chai; William Fisher; Qizhi Yao
Journal:  World J Surg       Date:  2005-03       Impact factor: 3.352

Review 7.  Production and function of cytokines in natural and acquired immunity to Candida albicans infection.

Authors:  R B Ashman; J M Papadimitriou
Journal:  Microbiol Rev       Date:  1995-12

8.  Protective activity of thymosin against opportunistic infections in animal models.

Authors:  H Ishitsuka; Y Umeda; J Nakamura; Y Yagi
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

9.  A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission.

Authors:  A M Liberati; E Ballatori; M Fizzotti; M Schippa; L Cini; S Cinieri; M G Proietti; R Di Marzio; M Senatore; F Grignani
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.